These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1581 related articles for article (PubMed ID: 8951358)

  • 41. A feasibility study of a deuterium-deuterium neutron generator-based boron neutron capture therapy system for treatment of brain tumors.
    Hsieh M; Liu Y; Mostafaei F; Poulson JM; Nie LH
    Med Phys; 2017 Feb; 44(2):637-643. PubMed ID: 28205309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 10B-editing 1H-detection and 19F MRI strategies to optimize boron neutron capture therapy.
    Capuani S; Porcari P; Fasano F; Campanella R; Maraviglia B
    Magn Reson Imaging; 2008 Sep; 26(7):987-93. PubMed ID: 18486394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Boron neutron capture therapy for malignant brain tumors.
    Miyatake SI; Wanibuchi M; Hu N; Ono K
    J Neurooncol; 2020 Aug; 149(1):1-11. PubMed ID: 32676954
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Neutron capturing irradiation: principle, current results and perspectives].
    Pignol JP; Chauvel P
    Bull Cancer Radiother; 1995; 82(3):283-97. PubMed ID: 8554878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Boron microlocalization in oral mucosal tissue: implications for boron neutron capture therapy.
    Morris GM; Smith DR; Patel H; Chandra S; Morrison GH; Hopewell JW; Rezvani M; Micca PL; Coderre JA
    Br J Cancer; 2000 Jun; 82(11):1764-71. PubMed ID: 10839288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Computational assessment of deep-seated tumor treatment capability of the 9Be(d,n)10B reaction for accelerator-based boron neutron capture therapy (AB-BNCT).
    Capoulat ME; Minsky DM; Kreiner AJ
    Phys Med; 2014 Mar; 30(2):133-46. PubMed ID: 23880544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Possibilities of boron neutron capture therapy in the treatment of malignant brain tumors].
    Kanygin VV; Kichigin AI; Gubanova NV; Taskaev SY
    Vestn Rentgenol Radiol; 2015; (6):36-42. PubMed ID: 26999933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
    Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
    Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Boronated starburst dendrimer-monoclonal antibody immunoconjugates: evaluation as a potential delivery system for neutron capture therapy.
    Barth RF; Adams DM; Soloway AH; Alam F; Darby MV
    Bioconjug Chem; 1994; 5(1):58-66. PubMed ID: 8199235
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of electroporation on cell killing by boron neutron capture therapy using borocaptate sodium (10B-BSH).
    Ono K; Kinashi Y; Masunaga S; Suzuki M; Takagaki M
    Jpn J Cancer Res; 1998 Dec; 89(12):1352-7. PubMed ID: 10081497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Critical evaluation of bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors.
    Liu L; Barth RF; Adams DM; Soloway AH; Reisfeld RA
    Anticancer Res; 1996; 16(5A):2581-7. PubMed ID: 8917355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Performance characteristics of the MIT fission converter based epithermal neutron beam.
    Riley KJ; Binns PJ; Harling OK
    Phys Med Biol; 2003 Apr; 48(7):943-58. PubMed ID: 12701897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fluorinated borono-phenylalanine for optimizing BNCT: Enhancing boron absorption against hydrogen scattering for thermal neutrons.
    Romanelli G; Capuani S; Onorati D; Ulpiani P; Preziosi E; Andreani C; Senesi R
    Med Phys; 2024 Jan; 51(1):439-446. PubMed ID: 37956252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
    Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
    Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeted drug delivery for boron neutron capture therapy.
    Mehta SC; Lu DR
    Pharm Res; 1996 Mar; 13(3):344-51. PubMed ID: 8692724
    [TBL] [Abstract][Full Text] [Related]  

  • 56. On the optimal energy of epithermal neutron beams for BNCT.
    Biscegliet E; Colangelo P; Colonna N; Santorelli P; Variale V
    Phys Med Biol; 2000 Jan; 45(1):49-58. PubMed ID: 10661582
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New horizons for therapy based on the boron neutron capture reaction.
    Hawthorne MF
    Mol Med Today; 1998 Apr; 4(4):174-81. PubMed ID: 9572059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multi-Functional Boron-Delivery Agents for Boron Neutron Capture Therapy of Cancers.
    Oloo SO; Smith KM; Vicente MDGH
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. From Nuclear Reactor-Based to Proton Accelerator-Based Therapy: The Finnish Boron Neutron Capture Therapy Experience.
    Porra L; Wendland L; Seppälä T; Koivunoro H; Revitzer H; Tervonen J; Kankaanranta L; Anttonen A; Tenhunen M; Joensuu H
    Cancer Biother Radiopharm; 2023 Apr; 38(3):184-191. PubMed ID: 36269660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption.
    Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):663-72. PubMed ID: 9112465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 80.